The implantable cardioverter-defibrillator: An update

Jared D. Miller, Omair Yousuf, Ronald D. Berger

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

The implantable cardioverter-defibrillator (ICD) provides life-saving therapy to prevent sudden cardiac death. ICDs have been implanted in millions of patients worldwide since the first human implant in 1980. Clinical trials have helped establish guidelines for ICD implantation in primary and secondary prevention of sudden cardiac death. Recent trials have also tested and compared various programing strategies to avoid unnecessary shocks and improve survival among ICD recipients. ICDs may also assist with monitoring for heart failure management. In this review, we discuss the clinical science to date that has helped define the role of ICDs in current practice.

Original languageEnglish (US)
Pages (from-to)606-611
Number of pages6
JournalTrends in Cardiovascular Medicine
Volume25
Issue number7
DOIs
StatePublished - Oct 1 2015

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this